Titlebook: Rare Kidney Tumors; Comprehensive Multid Gabriel G. Malouf,Nizar M. Tannir Book 2019 Springer Nature Switzerland AG 2019 Rare Kidney Cancer

蓋他為秘密

高爾夫

Wilms Tumor-Nephroblastoma,ing for 5% of all malignancies and 80% of all diagnosed renal cancers in children and teenagers. The overall survival has increased to over 90% due to international collaboration in cooperative group studies and employment of a multimodal treatment approach including surgery, radiation, and chemothe

FIN

Expiration

Processes

Papillary Renal Cell Carcinoma,r approximately 15–20% of renal malignancies [1, 2]. The term papillary RCC is a histologic designation, and the diagnosis is based on the presence of papillary or tubulopapillary structures on histopathologic evaluation. Historically, two histologic subtypes of papillary RCC, type 1 and type 2, hav

CHASE

打擊

血友病

TFE/Translocation Morphology Renal Cell Carcinoma,haracteristic morphology and immunohistochemical expression of TFE3 or TFEb. Cytogenetic translocations may include TFE3-ASPS, TFE3-PRCC, TFEb-alpha, or other variants; mechanisms for TFE upregulation may be heterogenous. TFE3 and TFEB are members of the MiTF/TFE family of basic helix-loop-helix-leu

Infusion

知識